Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pd-1 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05068427
What this trial is testing

Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC.

Who this might be right for
Non Small Cell Lung Cancer
Chipscreen Biosciences, Ltd. 34
Not applicableActive Not RecruitingNCT07147361
What this trial is testing

Predictive Biomarkers for PD-1 Inhibitor Response in Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)Cervical Squamous Cell CarcinomaLung Squamous Cell Carcinoma+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 800
Testing effectiveness (Phase 2)Study completedNCT05414461
What this trial is testing

Efficacy of Combination Immunotherapy in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
First Affiliated Hospital of Zhejiang University 97
Testing effectiveness (Phase 2)Looking for participantsNCT06501391
What this trial is testing

Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Stable Brain Metastasis

Who this might be right for
NSCLC Stage IVBrain Metastases
Fudan University 54
Large-scale testing (Phase 3)Looking for participantsNCT05357846
What this trial is testing

PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)

Who this might be right for
Squamous Cell Esophageal CarcinomaEsophageal CancerOesophageal Cancer
Sun Yat-sen University 422
Testing effectiveness (Phase 2)Study completedNCT04209686
What this trial is testing

Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma

Who this might be right for
Advanced Gastric Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Not applicableLooking for participantsNCT05772273
What this trial is testing

PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 43
Not applicableStudy completedNCT05332496
What this trial is testing

TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCC

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 941
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06751394
What this trial is testing

Preoperative Chemoradiotherapy and Toripalimab in Locally Recurrent Rectal Cancer

Who this might be right for
Recurrent Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 44
Testing effectiveness (Phase 2)UnknownNCT05824494
What this trial is testing

Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors

Who this might be right for
Uterine Cervical NeoplasmsCancer of CervixCervical Cancer+3 more
Women's Hospital School Of Medicine Zhejiang University 58
Not applicableStudy completedNCT06631326
What this trial is testing

HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)

Who this might be right for
HCC - Hepatocellular CarcinomaHepatic Arterial Infusion ChemotherapyBCLC Stage C Hepatocellular Carcinoma+2 more
First Hospital of China Medical University 244
Testing effectiveness (Phase 2)UnknownNCT04995120
What this trial is testing

Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Laryngeal/Hypopharyngeal Carcinoma

Who this might be right for
Laryngeal CancerHypopharynx CancerLaryngeal Neoplasms
Fudan University 42
Testing effectiveness (Phase 2)UnknownNCT05281003
What this trial is testing

Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic Oncology Projects 2004, ECTOP-2004)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 128
Testing effectiveness (Phase 2)Active Not RecruitingNCT07646717
What this trial is testing

Efficacy and Safety of HAIC Combined With Lenvatinib and PD-1 Inhibitors for Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableLooking for participantsNCT05392413
What this trial is testing

Immune Indicator Model for Predicting Efficacy of PD-1 Monoclonal Antibody

Who this might be right for
Esophageal Squamous Cell CarcinomaPD-1 Inhibitor
Nanfang Hospital, Southern Medical University 200
Testing effectiveness (Phase 2)Looking for participantsNCT05187338
What this trial is testing

Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors

Who this might be right for
Lung CancerLiver CancerColorectal Cancer+8 more
Second Affiliated Hospital of Guangzhou Medical University 100
Early research (Phase 1)Looking for participantsNCT06431685
What this trial is testing

Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer

Who this might be right for
NSCLCLow Dose RadiotherapyPD-1 Inhibitor+1 more
Sichuan University 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03016338
What this trial is testing

Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
University Health Network, Toronto 51
Not applicableUnknownNCT04101747
What this trial is testing

To Explore the Diversity of Intestinal Flora in Patients With Advanced HCC Combin ed With Anti-PD-1 and Targeted Drug Therapy and the Correlation Between Metabolites and Therapeutic Effect

Who this might be right for
Advanced Hepatocellular Carcinoma
Sun Yat-sen University 30
Large-scale testing (Phase 3)Looking for participantsNCT06533384
What this trial is testing

PARPi or Capecitabine Combined With PD-1 Inhibitors as Adjuvant Therapy in High-risk TNBC

Who this might be right for
Triple-negative Breast Cancer
Guangdong Provincial People's Hospital 310
Next Page